Literature DB >> 24656610

Daclizumab in multiple sclerosis: a high-yield extension study.

Frederik Barkhof1, Olga Ciccarelli2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24656610     DOI: 10.1016/S1474-4422(14)70056-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  1 in total

1.  GFAPα IgG-associated encephalitis upon daclizumab treatment of MS.

Authors:  Felix Luessi; Sinah Engel; Annette Spreer; Stefan Bittner; Frauke Zipp
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.